Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

MIXED(2)
1 unique interventions1 categories

Analytics

Trial Phases

No phase data

Trial Status

Recruiting2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT07487883Recruiting
Cadherin 3(CDH3)-Targeted PET in Lung Malignant Tumors
Malignant NeoplasmNon-Small Cell Lung CancerPET/CT+1 more
PrincipalinvestigatorStart date: 2026-03-18
NCT07498933Recruiting
FAP-targeted PET/NIR in Lung Malignant Tumors
Neoadjuvant TherapyNon-Small Cell Lung CancerPET/CT
PrincipalinvestigatorStart date: 2025-06-03

Research Network

Collaboration Network

18 collaborators·30 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Peking University People's Hospital

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Yuan Li, MD

Peking University People's Hospital

Similar
2 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungPET/CTCancer+2 more

Worked with same sponsors:

Peking University People's Hospital
Collaborated on 2 trials
Similarity Score58%

Kezhong Chen, MD

Peking University People's Hospital

Similar
4 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungPET/CTCancer+2 more

Worked with same sponsors:

Peking University People's Hospital
Collaborated on 2 trials
Similarity Score58%

Jun Wang, M.M.

Peking University People's Hospital

Similar
3 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungPET/CTCancer+2 more

Worked with same sponsors:

Peking University People's Hospital
Collaborated on 2 trials
Similarity Score58%

Xing Yang, MD

Peking University People's Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

CancerCarcinoma, Non-Small-Cell LungPET/CT+1 more

Worked with same sponsors:

Peking University People's Hospital
Collaborated on 1 trial
Similarity Score44%

Ziqian Bai, MD

Peking University People's Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

CancerCarcinoma, Non-Small-Cell LungPET/CT+1 more

Worked with same sponsors:

Peking University People's Hospital
Collaborated on 1 trial
Similarity Score44%

Zhaohui Zhu, MD

Peking Union Medical College Hospital

Moderately Similar
19 trials

Shared therapeutic areas:

Neoadjuvant TherapyCarcinoma, Non-Small-Cell LungPET/CT

Worked with same sponsors:

Peking University People's Hospital
Collaborated on 1 trial
Similarity Score34%

Urielle Desalbres

Assistance Publique Hôpitaux de Marseille

Related
71 trials

Shared therapeutic areas:

CancerCarcinoma, Non-Small-Cell Lung
Similarity Score12%

Brigitte C Widemann, M.D.

National Cancer Institute (NCI)

Related
19 trials

Shared therapeutic areas:

Cancer
Similarity Score6%

loic MONDOLONI

Assistance Publique Hopitaux De Marseille

Related
28 trials

Shared therapeutic areas:

Cancer
Similarity Score6%

emilie garrido pradalie

APHM

Related
35 trials

Shared therapeutic areas:

Cancer
Similarity Score6%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT07487883PrincipalInvestigator

Cadherin 3(CDH3)-Targeted PET in Lung Malignant Tumors

Malignant NeoplasmNon-Small Cell Lung CancerPET/CT+1 more
Recruiting
NCT07498933PrincipalInvestigator

FAP-targeted PET/NIR in Lung Malignant Tumors

Neoadjuvant TherapyNon-Small Cell Lung CancerPET/CT
Recruiting

All 2 trials loaded